Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Everi | EVRI | Nov 27, 2024 | 13.46 | -0.15 |
EverQuote A | EVER | Nov 27, 2024 | 19.16 | -2.59 |
Eversource Energy | ES | Nov 27, 2024 | 64.59 | +1.59 |
Everspin Technologies | MRAM | Nov 27, 2024 | 6.10 | -0.16 |
Evertec | EVTC | Nov 27, 2024 | 35.85 | +0.34 |
Everus Construction Group, Inc. When Issued | ECG | Nov 27, 2024 | 64.66 | 0.00 |
EVgo | EVGO | Nov 27, 2024 | 6.47 | -0.31 |
EVI Industries | EVI | Nov 27, 2024 | 19.06 | +0.90 |
Evogene | EVGN | Nov 27, 2024 | 1.69 | +4.14 |
Evoke Pharma | EVOK | Nov 27, 2024 | 4.37 | -0.46 |
Evolent Health A | EVH | Nov 27, 2024 | 12.93 | -2.49 |
Evolus | EOLS | Nov 27, 2024 | 13.80 | +7.56 |
Evolution Petroleum | EPM | Nov 27, 2024 | 5.80 | +1.05 |
Evolv Technologies A | EVLV | Nov 27, 2024 | 3.92 | +13.81 |
Evotec ADR | EVO | Nov 27, 2024 | 4.83 | +1.47 |
Exact Sciences | EXAS | Nov 27, 2024 | 61.69 | +2.65 |
Exagen | XGN | Nov 27, 2024 | 3.84 | -2.54 |
Excelerate Energy | EE | Nov 27, 2024 | 30.69 | +1.79 |
ExcelFin Acquisition A | XFIN | Nov 27, 2024 | 9.24 | 0.00 |
Exela Technologies | XELA | Nov 27, 2024 | 1.98 | 0.00 |
Exela Technologies B Pref | XELAP | Nov 27, 2024 | 1.23 | 0.00 |
Exelixis | EXEL | Nov 27, 2024 | 35.93 | -1.43 |
Exelon | EXC | Nov 27, 2024 | 39.51 | +0.05 |
Exicure | XCUR | Nov 27, 2024 | 31.99 | +15.53 |
ExlService | EXLS | Nov 27, 2024 | 46.59 | -0.91 |
eXp World | EXPI | Nov 27, 2024 | 14.08 | +1.51 |
Expand Energy | EXE | Nov 27, 2024 | 98.75 | 0.00 |
Expedia | EXPE | Nov 27, 2024 | 184.92 | -0.73 |
Expeditors International of Washington | EXPD | Nov 27, 2024 | 121.25 | -0.33 |
Expensify A | EXFY | Nov 27, 2024 | 3.27 | -2.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.